StockData
Satellos Bioscience Inc. logo

Satellos Bioscience Inc. (MSLE) shareholders

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$6.20−0.27 (-4.17%)

Close on Nov 17, 2026Market cap $95.85MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
49.7%
8M of 15M shares
Institutional holders
26
2 new, 7 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Qiming U.S. Healthcare Fund III, L.P.
Joint filing with Qiming U.S. Healthcare GP III, LLC (8.30%), Mark McDade (8.30%) and 1 more
1,725,2478.30%13G (passive)Mar 31, 2026
Brian Matthew Bloom
Joint filing with Bloom Burton & Co. Inc. (6.53%), Jolyon David Burton (6.53%)
1,133,4017.35%13G (passive)Feb 6, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MSLEValueChange% of portfolio
Franklin Resources Inc938,6666.07%$7.23M–0.00%
Siren, L.L.C.892,0745.77%$6.94M–0.14%
Vivo Capital, LLC813,6665.26%$6.33M–0.58%
Point72 Asset Management, L.P.682,7004.42%$5.31M−8,0780.01%
Sphera Funds Management Ltd.652,5904.22%$5.07M+163,3830.66%
Woodline Partners LP500,4323.24%$3.89M–0.01%
Stonepine Capital Management, LLC491,6243.18%$3.72M+391,6242.10%
Suvretta Capital Management, LLC475,0003.07%$3.69M–0.07%
Avidity Partners Management LP387,7692.51%$3.01M−387,7690.48%
Saturn V Capital Management LP350,0002.26%$2.72M–0.39%
Soleus Capital Management, L.P.314,3592.03%$2.44M−100,0000.08%
683 Capital Management, LLC230,8331.49%$1.79M–0.09%
ADAR1 Capital Management, LLC222,5551.44%$1.73M–0.08%
AWM Investment Company, Inc.180,0001.16%$1.40MNew0.12%
Millennium Management LLC152,7680.99%$1.19M−145,6650.00%
Adage Capital Partners Gp, L.L.C.150,0000.97%$1.17M−230,3540.00%
Empery Asset Management, LP107,1000.69%$832.70K−123,0000.96%
Citadel Advisors LLC67,7380.44%$526.66K+25,2460.00%
Morgan Stanley25,7320.17%$200.07K+4,5490.00%
China Universal Asset Management Co., Ltd.20,0000.13%$155.50K+13,6000.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026268M49.7%2 / 67 / 71M1M
Q1 2026318M51.7%31 / 00 / 08M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of MSLEValue% of fundAs of
Franklin Biotechnology Discovery Fund246,4071.59%$2.46M0.21%Jul 31, 2026
Franklin Biotechnology Discovery Fund96,8300.63%$689.82K0.08%Jul 31, 2026
Fidelity Nasdaq Composite Index Fund11,9070.08%$86.92K0.00%May 31, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.82%
0M shares short
Days to cover
3.9
At 0M shares a day
Change since last report
+30.7%
From 0M shares
Short volume, 20 days
46.3%
Of volume reported to FINRA

Shares sold short, last 9 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Satellos Bioscience's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,923 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?